I faced breast cancer and unexpected body changes with resilience and humor, learning to adapt and find strength in the ...

The accelerated approval is for the treatment of adult and pediatric patients aged one year and older with diffuse midline glioma harboring an H3 K27M mutation and progressive disease following prior ...

Dr. Patrick J. Hensley shares the treatment landscape of non-muscle-invasive bladder, as well as how individual risk factors can alter treatment options.

Cancer during pregnancy is rare but increasingly recognized as maternal age rises and non-invasive prenatal testing becomes ...

A diagnosis of stage 1 urothelial carcinoma can be overwhelming, but it is an early-stage cancer with excellent prognosis and ...

In the discussion, Petrylak highlighted advances in identifying genetic mutations and emerging strategies for early, ...

As a metastatic breast cancer patient, I want to control what I can, including my diet and exercise.

Ibtrozi may become the new standard for ROS1-mutated lung cancer, with phase 2 data showing safer, longer-lasting benefits ...

The regulatory approval of the oral estrogen receptor antagonist is for patients whose cancer has an ESR1 mutation and has ...

Frontline: Surgery (adrenalectomy) to remove the affected adrenal gland is the standard treatment. Second line: Mitotane, a ...

Davis, who is 30 years old, is the mother of a 16-month-old son and works as a pediatric emergency room nurse at Hackensack ...

Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) ...